Cod-THC
Cod-THC (Codeine Δ 9 -tetrahydrocannabinol carbonate) is a synthetic codrug formed by linking tetrahydrocannabinol with codeine via a carbonate bridge.
≈ 4 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Cod-THC (Codeine Δ9-tetrahydrocannabinol carbonate) is a synthetic codrug formed by linking tetrahydrocannabinol with codeine via a carbonate bridge. It is well absorbed orally and shows superior analgesic effects in animal studies compared to a simple mixture of the two drugs.[1][2][3]
THC can partially inhibit CYP2D6, which is the enzyme that transforms codeine into its active metabolite morphine.[4][5] It's not well understood how THC may impact codeines metabolism in humans.
See also
edit edit sourceReferences
edit edit source- ^ Banerjee A, Hayward JJ, Trant JF (May 2023). ""Breaking bud": the effect of direct chemical modifications of phytocannabinoids on their bioavailability, physiological effects, and therapeutic potential". Organic & Biomolecular Chemistry. 21 (18): 3715–3732. doi:10.1039/d3ob00068k. PMID 36825573. Wikipedia revision 1346557661, retrieved 2026-11-20
- ^ US 2008176885A1, Holtman JR, Crooks PA, Dhooper HK, "Novel synergistic opioid-cannabinoid codrug for pain management", published 24 July 2008, assigned to University of Kentucky and Insys Therapeutics Inc Wikipedia revision 1346557661, retrieved 2026-11-20
- ^ Crooks PA, Dhooper HK, Chakraborty U (2010). "Improving the Use of Drug Combinations Through the Codrug Approach". Prodrugs and Targeted Delivery. Methods and Principles in Medicinal Chemistry. Vol. 47. pp. 345–383. doi:10.1002/9783527633166.ch13. ISBN 978-3-527-32603-7. Wikipedia revision 1346557661, retrieved 2026-11-20
- ^ Nasrin S, Watson CJ, Perez-Paramo YX, Lazarus P (December 2021). "Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions". Drug Metabolism and Disposition. 49 (12): 1070–1080. doi:10.1124/dmd.121.000442. PMC 11022895. PMID 34493602. Wikipedia revision 1346557661, retrieved 2026-11-20
- ^ Huff HC, Vasan A, Roy P, Kaul A, Tajkhorshid E, Das A (September 2021). "Differential Interactions of Selected Phytocannabinoids with Human CYP2D6 Polymorphisms". Biochemistry. 60 (37): 2749–2760. doi:10.1021/acs.biochem.1c00158. PMC 8455456. PMID 34491040. Wikipedia revision 1346557661, retrieved 2026-11-20
(comparison)
- Arachidonoyl ethanolamide (AEA; anandamide)
- 2-Arachidonoylglycerol (2-AG)
- 2-Arachidonyl glyceryl ether (2-AGE; noladin ether)
- 2-Oleoylglycerol (2-OG)
- N-Arachidonoyl dopamine (NADA)
- N-Arachidonylglycine (NAGly)
- 2-Arachidonoyl lysophosphatidylinositol (2-ALPI)
- N-Arachidonoyl serotonin (AA-5-HT)
- Docosatetraenoylethanolamide (DEA)
- Lysophosphatidylinositol (LPI)
- Oleamide
- Oleoylethanolamide (OEA)
- Palmitoylethanolamide (PEA)
- RVD-Hpα
- Stearoylethanolamide (SEA)
- O-Arachidonoyl ethanolamine (O-AEA; virodhamine)
cannabinoid
receptor
agonists /
neocannabinoids
enhancers
(inactivation inhibitors)
- 4-Nonylphenylboronic acid
- AM-404
- Arachidonoyl serotonin
- ART26.12
- Arvanil
- BIA 10-2474
- Biochanin A
- CAY-10401
- CAY-10429
- Genistein
- Guineesine
- IDFP
- Irafamdastat
- JNJ 1661010
- JNJ-42165279
- JZL184
- JZL195
- Kaempferol
- LY-2183240
- MK-4409
- O-1624
- O-2093
- O-7460
- Oleoylethanolamide (OEA)
- Olvanil
- Palmitoylethanolamide (PEA)
- PF-04457845
- PF-622
- PF-750
- PF-3845
- PHOP
- UCM707
- URB-447
- URB-597
- URB-602
- URB-754
- VDM-11
(antagonists/inverse
agonists/antibodies)
- ABD459
- AM-251
- AM-281
- AM-630
- AM-1387
- AM-4113
- AM-6527
- AM-6545
- Amauromine
- ANEB-001
- AZD-2207
- BML-190
- CAY-10508
- CB-25
- CB-52
- CB-86
- CE-178253
- COR170
- Drinabant (AVE1625)
- Hemopressin
- Ibipinabant (SLV319)
- JD-5037
- JTE-907
- LH-21
- LY-320,135
- MDA-77
- MJ-15
- MK-9470
- Monlunabant
- MRL-650
- NESS-0327
- NIDA-41020
- O-606
- O-1184
- O-1248
- O-1918
- O-2050
- O-2654
- Otenabant (CP-945,598)
- PF-514273
- PGN36
- PipISB
- PSB-SB-487
- Rezosicone
- Rimonabant (SR141716)
- Rosonabant (E-6776)
- SLV 319
- SR-144,528
- Surinabant (SR147778)
- Taranabant (MK-0364)
- TC-C 14G
- TM-38837
- VCHSR
- Voacamine
- Zevaquenabant
- See also: Cannabinoid receptor modulators (cannabinoids by pharmacology)
- List of: AM cannabinoids
- JWH cannabinoids
- Designer drugs § Synthetic cannabimimetics
Text derived from https://en.wikipedia.org/w/index.php?oldid=1346557661 under CC BY-SA 4.0; modifications have been made.